These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 33213294)

  • 21. Structure-based identification of potential SARS-CoV-2 main protease inhibitors.
    Khan S; Fakhar Z; Hussain A; Ahmad A; Jairajpuri DS; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2022 May; 40(8):3595-3608. PubMed ID: 33210561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
    Fadaka AO; Aruleba RT; Sibuyi NRS; Klein A; Madiehe AM; Meyer M
    J Biomol Struct Dyn; 2022 May; 40(8):3416-3427. PubMed ID: 33200673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of
    Hendi AA; Virk P; Awad MA; Elobeid M; Ortashi KMO; Alanazi MM; Alkallas FH; Almoneef MM; Abdou MA
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease.
    Joshi T; Joshi T; Pundir H; Sharma P; Mathpal S; Chandra S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6728-6746. PubMed ID: 32752947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.
    Shode FO; Idowu ASK; Uhomoibhi OJ; Sabiu S
    J Biomol Struct Dyn; 2022 Sep; 40(14):6587-6602. PubMed ID: 33590806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial based natural compounds as potential inhibitors for SARS-CoV-2 Papain-like protease (PLpro): a molecular docking and dynamic simulation study.
    Rahul S; Sarkar A
    J Biomol Struct Dyn; 2022; 40(24):13848-13858. PubMed ID: 34730069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.
    Gogoi M; Borkotoky M; Borchetia S; Chowdhury P; Mahanta S; Barooah AK
    J Biomol Struct Dyn; 2022 Sep; 40(15):7143-7166. PubMed ID: 33715595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
    Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
    J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies.
    Patil VR; Dhote AM; Patil R; Amnerkar ND; Lokwani DK; Ugale VG; Charbe NB; Firke SD; Chaudhari P; Shah SK; Mehta CH; Nayak UY; Khadse SC
    J Biomol Struct Dyn; 2023; 41(22):13168-13179. PubMed ID: 36757134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plant-derived chemicals as potential inhibitors of SARS-CoV-2 main protease (6LU7), a virtual screening study.
    Sisakht M; Mahmoodzadeh A; Darabian M
    Phytother Res; 2021 Jun; 35(6):3262-3274. PubMed ID: 33759279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro).
    Khan A; Ali SS; Khan MT; Saleem S; Ali A; Suleman M; Babar Z; Shafiq A; Khan M; Wei DQ
    J Biomol Struct Dyn; 2021 Aug; 39(13):4659-4670. PubMed ID: 32552361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential antivirals against 3CLpro enzyme for the treatment of SARS-CoV-2: A multi-step virtual screening study.
    Kumar V; Kar S; De P; Roy K; Leszczynski J
    SAR QSAR Environ Res; 2022 May; 33(5):357-386. PubMed ID: 35380087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metadynamics-based enhanced sampling protocol for virtual screening: case study for 3CLpro protein for SARS-CoV-2.
    Namsani S; Pramanik D; Khan MA; Roy S; Singh JK
    J Biomol Struct Dyn; 2022 Sep; 40(15):7002-7017. PubMed ID: 33663346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases.
    Kumar BK; Faheem ; Sekhar KVGC; Ojha R; Prajapati VK; Pai A; Murugesan S
    J Biomol Struct Dyn; 2022 Feb; 40(3):1363-1386. PubMed ID: 32981461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.
    Muhammad I; Rahman N; Gul-E-Nayab ; Niaz S; Basharat Z; Rastrelli L; Jayanthi S; Efferth T; Khan H
    Comput Biol Med; 2021 Jun; 133():104362. PubMed ID: 33894500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.
    Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A
    J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Finding potent inhibitors for COVID-19 main protease (M
    Motiwale M; Yadav NS; Kumar S; Kushwaha T; Choudhir G; Sharma S; Singour PK
    J Biomol Struct Dyn; 2022 Mar; 40(4):1534-1545. PubMed ID: 33030102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL
    Alamri MA; Tahir Ul Qamar M; Mirza MU; Bhadane R; Alqahtani SM; Muneer I; Froeyen M; Salo-Ahen OMH
    J Biomol Struct Dyn; 2021 Aug; 39(13):4936-4948. PubMed ID: 32579061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular docking and simulation studies of natural compounds of
    Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
    J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.